6-Monoacetylmorphine (6-MAM)-BSA Antigen

As the principal 6-acetyl ester metabolite of heroin, 6-monoacetylmorphine (6-MAM) is the specific biomarker that distinguishes heroin use from other sources of morphine in toxicological screening. This Antibodies.com antigen conjugate presents 6-MAM as a hapten covalently linked to bovine serum albumin (BSA), a carrier protein strategy that renders the small-molecule drug metabolite immunogenic for antibody generation and assay development.

Supplied as a 1 mg liquid antigen-BSA conjugate, the reagent is formatted for ELISA workflows targeting the 6-MAM analyte in forensic, clinical, and research immunoassay panels. The conjugate can serve as an immunogen for polyclonal or monoclonal antibody production, or as a plate-coating antigen in competitive immunoassays calibrated against the heroin metabolite. Researchers developing drug-of-abuse testing kits, custom antibody validation panels, or opioid screening reagents rely on this hapten-carrier format to bridge small-analyte recognition with the protein-based architecture of standard immunoassays.

The liquid product form supports immediate dilution into buffer systems for plate coating or immunization protocols, with BSA providing the structural anchor for surface immobilization on microplate wells. Store refrigerated and protect from light to maintain the integrity of the hapten-BSA linkage and preserve antigen reactivity over the working shelf life.